RadNet Raises 2026 Guidance Amid Strong Performance
RadNet announced significant growth momentum during its Q1 2026 earnings call, signaling annual recurring revenue exceeding $140 million while raising full-year imaging center guidance by $30 million. The company reported record quarterly revenue and EBITDA figures, demonstrating operational excellence across its diversified portfolio. PET/CT imaging services showed particularly robust growth, reflecting strong demand in oncology and cardiology diagnostics. The DeepHealth artificial intelligence platform experienced a notable surge in annual recurring revenue, validating RadNet's strategic shift toward value-added diagnostic services and technology integration. These results underscore management's confidence in sustained market demand for advanced imaging solutions and the successful monetization of its technology investments.
MA
Tuesday, May 12, 2026 at 9:20 AM
0
0
1
1